Literature DB >> 22266229

Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model.

Hanping Wu1, Ravi B Patel, Yuanyi Zheng, Luis Solorio, Tianyi M Krupka, Nicholas P Ziats, John R Haaga, Agata A Exner.   

Abstract

Benign periablational enhancement (BPE) response to thermal injury is a barrier to early detection of residual tumor in contrast enhanced imaging after radio-frequency (RF) ablation. The objective of this study was to evaluate the role of quantitative of contrast-enhanced ultrasound (CEUS) in early differentiation of BPE from residual tumor in a BD-IX rat subcutaneous colon cancer model. A phantom study was first performed to test the validity of the perfusion parameters in predicting blood flow of two US contrast imaging modes-contrast harmonic imaging (CHI) and microflow imaging (MFI). To create a simple model of BPE, a peripheral portion of the tumor was ablated along with surrounding normal tissue, leaving part of the tumor untreated. First-pass dynamic enhancement (FPDE) and MFI scans of CEUS were performed before ablation and immediately, 1, 4 and 7 days after ablation. Time-intensity-curves in regions of BPE and residual tumor were fitted to the function y = A(1-exp[-β{t-t0}])+C, in which A, β, t0 and C represent blood volume, flow speed, time to start and baseline intensity, respectively. In the phantom study, positive linear correlations were noted between A, β, Aβ and contrast concentration, speed and flow rate, respectively, in both CHI and MFI. On CEUS images of the in vivo study, the unenhanced ablated zone was surrounded by BPE and irregular peripheral enhancement consistent with residual tumor. On days 0, 4 and 7, blood volume (A) in BPE was significantly higher than that in residual tumor in both FPDE imaging and MFI. Significantly greater blood flow (Aβ) was seen in BPE compared with residual tumor tissue in FPDE on day 7 and in MFI on day 4. The results of this study demonstrate that qualitative CEUS can be potentially used for early detection of viable tumor in post-ablation assessment.
Copyright © 2012 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266229      PMCID: PMC3280615          DOI: 10.1016/j.ultrasmedbio.2011.12.008

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  39 in total

Review 1.  Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results.

Authors:  R Lencioni; D Cioni; C Bartolozzi
Journal:  Abdom Imaging       Date:  2001 Jul-Aug

2.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion.

Authors:  K Wei; A R Jayaweera; S Firoozan; A Linka; D M Skyba; S Kaul
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

Review 3.  Radiofrequency ablation of malignant liver tumors.

Authors:  S A Curley
Journal:  Oncologist       Date:  2001

4.  Evaluation of the vascular architecture of hepatocellular carcinoma by micro flow imaging: pathologic correlation.

Authors:  Hong Yang; Guang-Jian Liu; Ming-De Lu; Hui-Xiong Xu; Xiao-Yan Xie
Journal:  J Ultrasound Med       Date:  2007-04       Impact factor: 2.153

5.  Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment.

Authors:  Christopher P Hsu; Mahmood K Razavi; Samuel K So; Ilian H Parachikov; David A Benaron
Journal:  J Vasc Interv Radiol       Date:  2005-11       Impact factor: 3.464

6.  Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning.

Authors:  T J Blokhuis; M C van der Schaaf; M P van den Tol; E F I Comans; R A Manoliu; J R M van der Sijp
Journal:  Scand J Gastroenterol Suppl       Date:  2004

7.  Formulation and characterization of echogenic lipid-Pluronic nanobubbles.

Authors:  Tianyi M Krupka; Luis Solorio; Robin E Wilson; Hanping Wu; Nami Azar; Agata A Exner
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

8.  Radiofrequency ablation: post-ablation assessment using CT perfusion with pharmacological modulation in a rat subcutaneous tumor model.

Authors:  Hanping Wu; Agata A Exner; Tianyi M Krupka; Brent D Weinberg; Ravi Patel; John R Haaga
Journal:  Acad Radiol       Date:  2009-03       Impact factor: 3.173

9.  Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.

Authors:  Ming-de Lu; Xiao-Ling Yu; An-Hua Li; Tian-An Jiang; Min-Hua Chen; Bao-Zhen Zhao; Xiao-Dong Zhou; Jin-Rui Wang
Journal:  Ultrasound Med Biol       Date:  2007-07-16       Impact factor: 2.998

10.  Effect of intratumoral injection of carboplatin combined with pluronic P85 or L61 on experimental colorectal carcinoma in rats.

Authors:  Tianyi M Krupka; Brent D Weinberg; Hanping Wu; Nicholas P Ziats; Agata A Exner
Journal:  Exp Biol Med (Maywood)       Date:  2007-07
View more
  5 in total

1.  Establishment of Rabbit Liver VX2 Tumor Model Using Percutaneous Puncture Inoculation of Tumor Fragment Guided and Evaluated by Ultrasonography.

Authors:  Hui-Ming Yi; Bao-Huan Cai; Xi Ai; Kai-Yan Li; Wei Zhang
Journal:  Curr Med Sci       Date:  2019-10-14

Review 2.  A Review of Clinical Applications for Super-resolution Ultrasound Localization Microscopy.

Authors:  Hui-Ming Yi; Matthew R Lowerison; Peng-Fei Song; Wei Zhang
Journal:  Curr Med Sci       Date:  2022-02-15

Review 3.  Advantages and Limitations of Focal Liver Lesion Assessment with Ultrasound Contrast Agents: Comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines.

Authors:  Liliana Chiorean; Claudio Tana; Barbara Braden; Cosmin Caraiani; Zeno Sparchez; Xin-Wu Cui; Ulrich Baum; Christoph F Dietrich
Journal:  Med Princ Pract       Date:  2016-06-17       Impact factor: 1.927

4.  Value of contrast-enhanced ultrasound for preoperative assessment of liver reserve function in patients with liver tumors.

Authors:  Huiming Yi; Baohuan Cai; Xi Ai; Ruobing Liu; Kaiyan Li; Wei Zhang
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240

5.  Early Identification of Residual Tumors following Microwave Ablation Using Contrast-Enhanced Ultrasonography in a Rabbit VX2 Liver Cancer Model.

Authors:  Huiming Yi; Baohuan Cai; Xi Ai; Kaiyan Li; Pengfei Song; Wei Zhang
Journal:  Biomed Res Int       Date:  2020-09-26       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.